Glutathione (GSH), the main redox buffer, has long been recognized as a pivotal modulator
of tumor initiation, progression and metastasis. It is also implicated in the resistance of …

Sonodynamic therapy (SDT) has emerged as a promising therapeutic modality for
anticancer treatments and is becoming a cutting-edge interdisciplinary research field. This …

The development of highly efficient, multifunctional, and biocompatible sonosensitizer is still
a priority for current sonodynamic therapy (SDT). Herein, a defect‐rich Ti‐based metal …

Sonodynamic therapy (SDT), which involves a combination of low-intensity ultrasound (US)
and a chemical sonosensitizer, has emerged as a promising minimally invasive and …

Sonodynamic therapy (SDT), which can generate reactive oxygen species (ROS) based on
sonosensitizers under ultrasound (US) to kill tumor cells, has emerged as a noninvasive …

Conventional sonodynamic therapy is unavoidably limited by the tumor microenvironment,
although many sonosensitizers have been developed to improve them to a certain extent …

Sonodynamic therapy (SDT) is a promising strategy for tumor treatment that satisfies all
requirements of penetrating deep-seated tissues without causing additional trauma …

The development and optimization of sonosensitizers for elevating intratumoral reactive
oxygen species (ROS) are definitely appealing in current sonodynamic therapy (SDT). Given …

Bacteria‐infected osteomyelitis is life‐threatening without effective therapeutic methods
clinically. Here, a rapid and effective therapeutic strategy to treat osteomyelitis through …

Intratumoral immunosuppressive microenvironment (ISM) remains the dominant limitation to
disable oncological immunotherapy such as immunogenic cell death (ICD). To resolve the …